on July 9th, pharmaceutical company LAEKNA-B (02105) spent 355,100 Hong Kong dollars to buy back 50,000 shares.
Kalbe Pharmaceuticals-B (02105) announced that on July 9, 2026, the company spent HK$ 355,100 to repurchase 50,000 shares, with a repurchase price of HK$6.98-7.37 per share.
LAEKNA-B (02105) announced that the company has repurchased 50,000 shares on July 9, 2026, at a total cost of 355,100 Hong Kong dollars. The repurchase price per share ranged from 6.98 to 7.37 Hong Kong dollars.
Related Articles
Langxun Technology's Shenzhen Stock Exchange Main Board IPO has been inquired about, focusing on third-party integrated circuit testing business.
Huatai (06886) issued 6.6 billion yuan short-term corporate bonds.
SIAPAI HEALTH (00314) repurchased 53,800 shares for HKD 75,000 on July 9th.
Langxun Technology's Shenzhen Stock Exchange Main Board IPO has been inquired about, focusing on third-party integrated circuit testing business.
Huatai (06886) issued 6.6 billion yuan short-term corporate bonds.
SIAPAI HEALTH (00314) repurchased 53,800 shares for HKD 75,000 on July 9th.
RECOMMEND
